Modified Post-Transplant Cyclophosphamide Combined With DCAG as a Bridge Followed by Busulfan, Fludarabine and Melphalan Based Conditioning Regimen for Children With Juvenile Myelomonocytic Leukemia
Latest Information Update: 04 Nov 2021
At a glance
- Drugs Cyclophosphamide (Primary) ; Decitabine (Primary) ; Aclarubicin; Antithymocyte globulin; Busulfan; Cytarabine; Fludarabine; Granulocyte colony-stimulating factors; Melphalan
- Indications Juvenile myelomonocytic leukaemia
- Focus Therapeutic Use
- 01 Oct 2018 New trial record